Huaiqihuang Treatment of Diabetic Kidney Disease: Inhibition of NF-κB Signaling Pathway and Reduction of Pro-Inflammatory Cytokines.

https://pubmed.ncbi.nlm.nih.gov/38115276

Huaiqihuang (HQH) may treat diabetic kidney disease (DKD) by inhibiting the NF-κB signaling pathway, reducing pro-inflammatory cytokines, and alleviating high glucose-induced injury in renal tubular epithelial cells.